The company, which was founded in Singapore and has its European headquarters in London, harnesses proprietary research, manufacturing and specialist treatment, with a view to meeting a growing demand for smarter healthcare.
David has extensive knowledge of the medtech sector and currently serves as CMO and Non-Executive Director of BetaMedTech, a Singapore-based healthcare development company. In his new role he will work to ensure that the core business pillars of Verita Healthcare Group – services, products and technology – are integrated and supported by strategic brand management, digital marketing and end-to-end sales systems, ultimately supporting the growth of the company.
Julian Andriesz, Founder and Group Chairman of Verita Health Group, commented on the appointment: “In order to harness our full potential, we need agile minds, clear vision and bold strategies to ensure that we deliver the promise of fully integrative healthcare. David has proven his strength in these and several other critical areas early in his career and I am very pleased to have him join our senior management team in leading Sales and Marketing.”
Mayo also commented: “Having spent the first half of my working life in advertising, I now want to spend the second half working in a sector with a company that gives back in a meaningful way. Disruption is everywhere but none more so than in the global health economy. The combination of increasing diseases, a growing population and a global healthcare system that is still focused on reactive sickness management instead of proactive healthcare, creates a perfect space for this disruption,” he said. “The global healthcare market is predicted to grow to around US$10 trillion by 2022 and it represents a significant proportion of global GDP, so it’s a good time to be disrupting rather than defending! With its global reach and strong leadership reputation, Verita is an exciting, challenging place to do that from.”